UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000053120
Receipt number R000060617
Scientific Title Relationship between locomotive syndrome and lifestyle-related diseases in people undergoing medical checkups
Date of disclosure of the study information 2023/12/18
Last modified on 2023/12/15 14:01:12

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Relationship between locomotive syndrome and lifestyle-related diseases in people undergoing medical checkups

Acronym

Relationship between locomotive syndrome and lifestyle-related diseases in people undergoing medical checkups

Scientific Title

Relationship between locomotive syndrome and lifestyle-related diseases in people undergoing medical checkups

Scientific Title:Acronym

Relationship between locomotive syndrome and lifestyle-related diseases in people undergoing medical checkups

Region

Japan


Condition

Condition

locomotive syndrome, lifestyle-related diseases

Classification by specialty

Geriatrics Orthopedics Rehabilitation medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

In this study, as basic research toward the construction of a lifestyle guidance program aimed at extending healthy life expectancy, we analyzed the relationship between locomotive syndrome and metabolic syndrome based on cross-sectional and longitudinal surveys on locomotive syndrome and lifestyle-related diseases, and analyzed the relationship between locomotive syndrome and metabolic syndrome. The purpose is to clarify the causal relationship between disabilities.

Furthermore, based on these research results, we will develop a lifestyle guidance program for middle-aged and elderly people, and by verifying the effectiveness of that program, we aim to construct a comprehensive lifestyle guidance program that will lead to longer healthy life expectancies.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Occurrence of locomotive syndrome and lifestyle-related diseases

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

90 years-old >=

Gender

Male and Female

Key inclusion criteria

Complete medical checkup recipient

Key exclusion criteria

Long-term care insurance users and persons certified as physically disabled

Target sample size

40000


Research contact person

Name of lead principal investigator

1st name Tomoyuki
Middle name
Last name Arai

Organization

Saitama Medical University

Division name

Department of Physical Therapy Faculty of Health and Medical Care

Zip code

350-0496

Address

981, Kawakado, Irumagun, Saitama 350-0436, Japan

TEL

0492951001

Email

arai_tm@saitama-med.ac.jp


Public contact

Name of contact person

1st name Tomoyuki
Middle name
Last name Arai

Organization

Saitama Medical University

Division name

Department of Physical Therapy Faculty of Health and Medical Care

Zip code

350-0496

Address

981, Kawakado, Irumagun, Saitama 350-0436, Japan

TEL

049-295-1001

Homepage URL


Email

arai_tm@saitama-med.ac.jp


Sponsor or person

Institute

Saitama Medical University

Institute

Department

Personal name



Funding Source

Organization

JSPS KAKENHI

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethical Committee of Saitama Medical University

Address

38 Morohongo, Moroyama-cho, Iruma-gun, Saitama

Tel

049-276-2143

Email

rinri@saitama-med.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 12 Month 18 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2020 Year 01 Month 15 Day

Date of IRB

2020 Year 01 Month 15 Day

Anticipated trial start date

2020 Year 01 Month 15 Day

Last follow-up date

2026 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Cross-sectional analysis will be conducted every year targeting those who took the Locomotive Motion Level Test from 2016 to March 2026.
Analyze the relationship between locomotive syndrome level and the results of each locomotive level test, lifestyle questionnaire, physical measurements, blood pressure, liver function, glucose tolerance, lipids, and bone density.

Longitudinal analysis will be conducted using data from people who continuously underwent medical checkups over a four-year period from 2016 to March 2020.
Analyze changes over time in the degree of locomotive behavior over a 4-year period.
Clarify the factors related to improvement and deterioration of locomotive syndrome from lifestyle questionnaire, physical measurements, blood pressure, liver function, glucose tolerance, lipids, and bone density.
Clarify whether improvement or worsening of locomotive syndrome affects lifestyle-related diseases.


Management information

Registered date

2023 Year 12 Month 15 Day

Last modified on

2023 Year 12 Month 15 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000060617


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name